Bevacizumab/paclitaxelDysphonia: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1518卷 / 1期

关键词：

D O I：

10.1007/s40278-014-3299-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：47 / 47

相关论文

共 50 条

[41] Bevacizumab/irinotecanNeutropenia and mucositis: 2 case reports
Reactions Weekly, 2021, 1871 (1) : 96 - 96
[42] Bevacizumab/dexamethasoneVarious toxicities: 6 case reports
Reactions Weekly, 2020, 1785 (1) : 112 - 112
[43] Bevacizumab/cyclophosphamideVarious toxicities: 5 case reports
Reactions Weekly, 2023, 1950 (1) : 92 - 92
[44] Bevacizumab/TemozolomideLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2030 (1) : 98 - 98
[45] Aflibercept/bevacizumab/ranibizumabEndophthalmitis: 15 case reports
Reactions Weekly, 2023, 1950 (1) : 21 - 21
[46] Bevacizumab/oxaliplatinVarious toxicities: 10 case reports
Reactions Weekly, 2011, 1365 (1) : 10 - 10
[47] Aflibercept/bevacizumab/ranibizumabCataract: 6 case reports
Reactions Weekly, 2022, 1887 (1) : 30 - 30
[48] Aflibercept/bevacizumab/ranibizumabEndophthalmitis: 7 case reports
Reactions Weekly, 2022, 1907 (1) : 28 - 28
[49] Aflibercept/bevacizumab/ranibizumabEndophthalmitis: 12 case reports
Reactions Weekly, 2023, 1971 (1) : 18 - 18
[50] Bevacizumab/ixabepiloneNeuropathy and mucositis: 2 case reports
Reactions Weekly, 2015, 1580 (1) : 66 - 66

← 1 2 3 4 5 →